After months of threats, President Trump eased up pressure on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing just fine. Talk of ...
Many might assume that over-the-counter (OTC) medications are generally safer than stronger prescription drugs, but research shows they can still present risks for some. "This is because they reduce ...
Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...
Leveraging Japan’s Appetite for U.S. Investment and Partnership in Pharmaceuticals and Biotechnology
Despite its strength in pharmaceuticals and biotechnology, the United States faces manufacturing challenges, including dependence on China for key inputs, which the National Security Commission on ...
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen®91% of study ...
TEXAS — Six women — including a former NASA rocket scientist, a bioastronautics research scientist, journalist Gayle King and music superstar Katy Perry — became astronauts after taking flight in a ...
New Phase I/II RGX-202 functional data demonstrates long-term, durable treatment effect at pivotal dose at 18 months Robust patient enrollment in confirmatory trial continues, expect majority of ...
The MarketWatch News Department was not involved in the creation of this content. -- New Phase I/II RGX-202 functional data demonstrates long-term, durable treatment effect at pivotal dose at 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results